Superworth

Tandem Diabetes Care EPS TNDM

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$0.93
Latest quarter, Q2 FY26
−$0.31
Fiscal year 2025
−$3.07

Tandem Diabetes Care's earnings per share was −$0.93 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.31.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$3.07n/a
FY2024−$1.46n/a
FY2023−$3.44n/a
FY2022−$1.48−717%
FY2021$0.24n/a
FY2020−$0.58n/a
FY2019−$0.48n/a
FY2018−$3.55n/a
FY2017−$16.14n/a
FY2016−$27.33n/a
FY2015−$25.30n/a
FY2014−$34.20n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.31n/a−$0.93
Q1 FY26−$0.30n/a−$1.40
Q4 FY25−$0.01−200%−$3.07
Q3 FY25−$0.31n/a−$3.05
Q2 FY25−$0.78n/a−$3.09
Q1 FY25−$1.97n/a−$2.78
Q4 FY24$0.01n/a−$1.46
Q3 FY24−$0.35n/a−$1.93
Q2 FY24−$0.47n/a−$2.09
Q1 FY24−$0.65n/a−$2.17
Q4 FY23−$0.46n/a−$3.44
Q3 FY23−$0.51n/a−$3.23

Against its peers

Companies in Medical - Instruments & Supplies nearest Tandem Diabetes Care's size, closest first, today.

CompanyEPS, 12 monthsGrowth
TNDMTandem Diabetes Care−$0.93
BVSBioventus$0.77
CDRECadre$0.81−14% a year
STAAStaar Surgical$0.07
IRMDIradimed$1.79+10% a year
EYENational Vision$0.61
LMATLemaitre Vascular$2.85+38% a year
INSPInspire Medical Systems$4.62+166% a year
MOVMovado$1.80+137% a year
UFPTUFP Technologies$9.28+8% a year
MDXGMimedx$0.04−81% a year
Peer median$1.30

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Tandem Diabetes Care

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.